Indena’s bioavailable curcumin formulation Meriva® at the XXIV International Congress on Sports Rehabilitation and Traumatology.
Milan, April 7th, 2015 – Indena’s involvement in the growing sports nutrition market is confirmed by the company’s participation in the Football Medicine Strategies for Player Care Conference, to be held at The Queen Elizabeth II Conference Centre on April 11th and 12th.
For over two decades this conference has been the meeting point of the international Football Medicine Community, and will gather some 1600 sports medicine specialists and professionals from 77 different countries around the world.
On this occasion, Indena will present a study on Meriva®, its proprietary lecithin-based and diet inspired delivery system of curcumin, confirming that its specific curcumin formulation may aid in sports nutrition by attenuating Delayed Onset Muscle Soreness (DOMS) due to eccentric muscle activity.
The interest for Meriva® in sports nutrition has been further confirmed in a second recent study published in 2015 by independent researchers from the Universities of Stirling and Malta, investigating the effect of a low dose of Meriva® supplementation on cytokine and inflammatory marker responses, following 2 hours of endurance cycling. This study could provide the basis for future investigations with larger samples and multiple Meriva® dosages to determine if different curcumin regimens can lead to statistically different interleukin levels when compared to a control and placebo in endurance cycling.
 Drobnic F, Riera J, Appendino G, Togni S, Franceschi F, Valle X, Pons A, Tur J, Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial, Journal of the International Society of Sports Nutrition 2014, 11:31
 Sciberras et al., The effect of turmeric (Curcumin) supplementation on cytokine and inflammatory marker responses following 2 hours of endurance cycling, Journal of the International Society of Sports Nutrition (2015) 12:5.
Meriva® is a patented delivery form of curcumin utilizing Indena proprietary Phytosome® technology, for healthy inflammatory response and joint health. Pharmacokinetic comparison studies have shown Meriva® to improve bioavailability of curcuminoids by about 30-fold and significant absorption benefits. The product is supported by 16 clinical trials demonstrating effectiveness for joint health and inflammatory response support.
Further info on Meriva® and other Phytosome®s: www.phytosomes.info
Please note this website is accessible from various countries all over the world and hence it may contain statements or product classification not applicable to your country. The claims made are in reference to ingredients only, hence they do not refer to finished products and they may not comply with Regulation 1924/2006/CE.The marketer of any finished product containing any ingredient is responsible for assuring that the destination of the product and the claims made for the finished product are lawful and comply with all applicable laws and regulations of the country or countries in which the product is to be sold.